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Pancreatic h cells play a central role in maintaining glucose homeostasis because they secrete insulin in response to increased level
of blood glucose; failure of this capacity constitutes a major component of the pathogenesis of diabetes. The identification of key
regulators of pancreatic h-cell differentiation is relevant for the overall understanding of this process and for future experiments aimed at
regenerating insulin-producing h cells from pancreatic or embryonic stem cells. Several studies using transgenic or knockout mice have
established that the development and function of pancreatic h cells are controlled by several genes encoding specific transcription
factors. By inactivating the homeobox gene Pax4, we previously demonstrated that its function is required for the formation of mature
insulin-producing cells. Here, we show that during pancreas ontogeny, Pax4 is expressed in differentiating endocrine cells, including h
cells. Pax4 activity appears essential for appropriate initiation of h-cell differentiation because loss of Pax4 prevents the expression of
Pdx1, HB9 and insulin in h-cell precursors. This role of Pax4 appears to be accomplished via its genetic interaction with another
homeobox gene, Nkx2.2.
D 2003 Elsevier Inc. All rights reserved.Keywords: Pax4; Nkx2.2; Pax6; Mouse; Pancreas; h-cell differentiation
edge will provide the molecular basis for generatingIntroduction
In mammals, the endocrine pancreas is composed of
four cell types (h-, a-, y-, and PP-cells) that collectively
regulate glucose homeostasis (Bramblett et al., 2000;
Slack, 1995). The role of h cells is fundamental; h cells
secrete insulin in response to an increased blood glucose
level after food intake, thereby regulating the circulating
level of glucose within a very narrow range. Maintenance
of the integrity of pancreatic h cells is essential for the
prevention of diabetes, a disease prevalent throughout
the world. In recent years, significant effort has been
made toward identifying the mechanism(s) responsible for
the specification and maturation of h cells; this knowl-0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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stem cells.
The early developing pancreatic epithelium contains
multipotent progenitors capable of giving rise to all pancre-
atic cell lineages (Gu et al., 2002; Herrera, 2002). Therefore,
a specific program of gene expression must restrict the
developmental potential of pancreatic progenitors and pro-
mote their differentiation. The identification and functional
characterization of transcription factors expressed in embry-
onic h cells have yielded important clues about the molec-
ular mechanisms that regulate the development of this cell
lineage (Bramblett et al., 2000; Edlund, 1999; Wilson et al.,
2003). For example, the basic helix-loop-helix (bHLH)
family member Ngn3 specifies an endocrine-cell fate
(Apelqvist et al., 1999; Gradwohl et al., 2000); Beta2/
NeuroD, another bHLH protein, regulates their appropriate
exit from the cell cycle (Naya et al., 1997); and Islet1, a
LIM-family member, controls the differentiation of postmi-
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activity of the NK-family member and homeodomain pro-
tein Nkx2.2 is necessary for the maturation of h cells
(Sussel et al., 1998), whereas its distant homologue
Nkx6.1 controls their expansion (Sander et al., 2000).
Finally, the corresponding functions of two members of
the Pax family of transcription factors, Pax4 and Pax6, are
also important for h-cell development (Dohrmann et al.,
2000; Sander et al., 1997; Sosa-Pineda et al., 1997; St-Onge
et al., 1997).
Our previous characterization of newborn Pax4-defi-
cient (Pax4/) mice showed that their pancreata were
almost entirely devoid of mature h cells, a result indicating
that Pax4 is a crucial regulator of h-cell development
(Sosa-Pineda et al., 1997). Many questions about the
function of Pax4 in the pancreas, however, still remain
unanswered; for example, what step does Pax4 control
during h-cell development, and what are the relative
positions of other factors in the Pax4-mediated pathway
in endocrine precursors?
To gain further insight into the role of Pax4 in h-cell
development, we performed a comparative analysis of gene
expression in the pancreata of wild-type and Pax4/
littermates at various developmental stages. We also sought
to identify possible genetic interactions between Pax4 and
two other genes (Pax6 and Nkx2.2) that also control h-cell
differentiation, by comparing the pancreatic alterations in
mice that are deficient in each of these genes and in mice
that are double-nullizygous for Pax4 and Nkx2.2 (Pax4/
Nkx2.2/). Overall, our results support the proposal that
Pax4 and Nkx2.2 are two key components of the molec-
ular machinery responsible for initiating pancreatic h-cell
differentiation.Materials and methods
Animals
Pax4 and Nkx2.2 heterozygous mice were generated by
homologous recombination as previously described (Sosa-
Pineda et al., 1997; Sussel et al., 1998); these animals were
maintained into an NMRI background. SeyNEU/+ mice have
been previously described (Hill et al., 1991). Pax4+/
Nkx2.2+/ double heterozygous mice were generated by
crossing animals carrying null alleles of Pax4 (Pax4+/)
and Nkx2.2 (Nkx2.2+/). Genotyping of mice and embryos
was performed as described previously (Hill et al., 1991;
Sosa-Pineda et al., 1997; Sussel et al., 1998).
Processing of embryos and pancreatic tissues
Tissues of dissected embryos or pancreata of newborn
mice to be analyzed by immunohistochemical methods or
in situ hybridization were fixed overnight by immersion
in 4% paraformaldehyde at 4jC. After this step, thetissues were subjected to cryoprotection in 30% sucrose
in phosphate-buffered saline (PBS) overnight at 4jC and
were then embedded in tissue-freezing medium (Tissue-
Tek, Triangle Biomedical Sciences). Tissues were cut into
sections (section width: 8–12 Am) with a cryostat.
Immunohistochemical analysis
Frozen sections were used for immunohistochemical
assays. Primary antibodies were the following: rat anti-
uvomorulin/E-cadherin (dilution ratio, 1:1,000; Sigma),
guinea pig anti-Islet1 / 2 (dilution ratio, 1:4,000; provided
by Jessell), guinea pig anti-Nkx2.2 (raised against a GST-
Nkx2.2 fusion protein; dilution ratio, 1:500), rabbit anti-
Nkx2.2 (dilution ratio, 1:1,000; provided by Jessell),
guinea pig anti-Ngn3 (dilution ratio, 1:2,000; provided
by German), rabbit anti-Nkx6.1 (dilution ratio, 1:1,000;
provided by Serup), rabbit anti-Pdx1 (dilution ratio,
1:1,000, provided by Wright), rabbit anti-HB9 (dilution
ratio, 1:4,000, provided by Kehrl), guinea pig anti-Pax6
(raised against a carboxy-terminus peptide of Pax6, cou-
pled to KLH; dilution ratio, 1:1,000), rabbit anti-Pax6
(dilution ratio, 1:1,000, provided by Mastick), rabbit anti-
h-galactosidase (dilution ratio 1:5,000; ICN), guinea pig
anti-insulin (dilution ratio, 1:250; DAKO), guinea pig
anti-glucagon (dilution ratio, 1:500; LINCO), rabbit anti
IAPP (amylin) (dilution ratio, 1:1,000; Advanced Chem-
Tech). For detection of the unlabeled primary antibodies,
the following secondary antibodies (dilution ratio 1:200)
were used: CY3-conjugated goat anti-rabbit IgG (Jackson
ImmunoResearch Laboratories, Inc.), CY3-conjugated
donkey anti-guinea pig IgG (Jackson), Alexa 488-conju-
gated goat anti-rabbit IgG (Molecular Probes), Alexa 488-
conjugated goat anti-rat IgG (Molecular Probes), Alexa
488-conjugated goat anti-mouse IgG (Molecular Probes),
FITC-conjugated donkey anti-guinea pig IgG (Jackson).
Images were obtained either with a Zeiss Axioskop 2
microscope and a Spot digital camera (Diagnostic Instru-
ments, Sterling Heights, MI) or with a Leica TCS
confocal laser-scanning microscope. Adobe Photoshop
version 5.5 (Adobe Systems, Inc.) was used to process
the images.
In situ hybridization
T3 or T7 RNA polymerase was used to produce sense
and antisense digoxigenin-labeled mRNA probes in vitro.
The templates were DNA subclones containing different
coding regions of Pax4 (600 bp fragment containing the
paired- and homedomain regions) and Pax6 (Hallonet et al.,
1998). Nonradioactive in situ hybridization was performed
on 10–12 Am frozen sections as described (Schaeren-
Wiemers and Gerfin-Moser, 1993) with the following mod-
ifications. Prehybridization was performed in a humidified
chamber at 55jC for 1–2 h with 500 Al prehybridization
buffer (50% formamide, 5 SSC, 50 Ag/ml yeast tRNA, 1%
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hybridization solution was prepared by adding 1 ng DIG
cRNA per 100 Al prehybridization buffer. The sections were
covered with plastic cover slips and not sealed. Post-
hybridization, slides were washed as described and then
incubated in 1MAB for 5 min at room temperature before
blocking (2% blocking reagent (Roche), 10% heat inacti-
vated sheep serum, 0.1% Tween-20 in 1 MAB) at room
temperature for 1 h. Blocking solution was replaced with
fresh blocking solution containing anti-DIG antibody (Fab
fragments) at a concentration of 1:5000 and incubated
overnight at 4jC. The slides were washed three times in
1 MAB with 0.1% Tween-20 for 15 min at room temper-
ature then washed in ddH2O with 0.1% Tween-20 for 20
min at room temperature. The bound probes were visualized
with an alkaline phosphatase-conjugated anti-digoxigenin
Fab fragment (Boehringer Mannheim).Results
Pax4 is transiently expressed in embryonic pancreatic
tissue
Using in situ hybridization, we previously showed expres-
sion of Pax4mRNA in the gut region of E9.5 mouse embryos
where the dorsal pancreatic anlage normally emerges (Sosa-
Pineda et al., 1997). Using the same approach, we also found
that the population of pancreatic Pax4-expressing cells in-
creased between E13.5 and E15.5, declined significantly
toward the end of gestation, and was absent in the adult
organ (Dohrmann et al., 2000; data not shown).
A detailed characterization of pancreatic cells expressing
Pax4 has been hampered by the lack of anti-Pax4 antibodies
suitable for immunohistochemistry. To overcome this prob-
lem, we characterized these cells in pancreatic tissues
isolated from Pax4+/ embryos. Pax4-heterozygous mice,
which otherwise appear normal, have an insertion of the h-
galactosidase (b-gal) reporter gene in one of two Pax4 loci
(Sosa-Pineda et al., 1997); this strategy allows the identifi-
cation of Pax4-expressing cells via immunolabeling with
anti-h-gal antibodies. We found that Pax4/h-gal proteins
were expressed in the same transient manner as Pax4
transcripts did: at E11.5, Pax4/h-gal+ cells were scattered
throughout the Pax4+/ pancreatic tissue (Fig. 1A); this
population reached its maximum between E13.5 and E15.5
(Fig. 1E). Toward the end of gestation, the number of Pax4/
h-gal+ cells decreased (Fig. 1L), and they were undetected
in pancreata of adult mice (data not shown).
At E11.5, some of the Pax4/h-gal+ cells detected in the
Pax4+/ pancreata coexpressed Ngn3 (Fig. 1B). Ngn3 is
transiently expressed in endocrine precursors and it is
required for their specification (Apelqvist et al., 1999;
Gradwohl et al., 2000). This result suggests that Pax4 is
expressed at around the time of endocrine specification and
supports the proposal that Ngn3 activates Pax4 gene ex-pression (Smith et al., 2003; Wilson et al., 2003). At E11.5,
we also found that most Pax4/h-gal+ cells coexpressed
Islet1, a transcription factor expressed in all differentiating
pancreatic endocrine cells (Fig. 1C) (Ahlgren et al., 1997;
Dohrmann et al., 2000; Grapin-Botton and Melton, 2000;
Jensen et al., 2000). This result indicates that in early
embryonic pancreata, Pax4-expressing cells largely repre-
sent differentiating endocrine precursors. At these stages,
low levels of Pax4/h-gal+ immunoreactivity also seemed to
be present in a small number of glucagon+ cells (Fig. 1D);
this result suggests that the early expression of Pax4 may
not be restricted to the h-cell and y-cell lineages.
During mouse pancreas ontogeny the peak of Pax4
expression (E13.5-E15.5; Fig. 1E) coincides with a period
of massive differentiation of endocrine precursors, the so-
called secondary transition (Pictet and Rutter, 1972). Mature
h-cells are thought to arise from precursors that initiate
differentiation at around this period (Bramblett et al., 2000;
Pictet and Rutter, 1972). In E15.5 Pax4+/ pancreata, we
observed that the population of Pax4/h-gal+ cells appeared
restricted to regions containing endocrine cells, including
differentiating h-cells (HB9+ cells; Fig. 1F); in contrast,
Pax4/h-gal+ cells was excluded from areas containing exo-
crine cells (compare Figs. 1E and G). This observation
suggesting that Pax4 is not expressed in pancreatic exocrine
tissue could not be corroborated using double-immunofluo-
rescence due to the lack of exocrine-specific antibodies
suitable for these experiments. At E15.5, various endocrine
markers such as Ngn3 (Fig. 1H), Islet1 (Fig. 1I), Nkx2.2 (data
not shown), and Pax6 (data not shown) colocalized with
Pax4/h-gal immunoreactivity; some Pax4/h-gal+ cells coex-
pressed insulin (Fig. 1J), and just a few of the glucagon+ cells
also appeared to express low levels of Pax4/h-gal (Fig. 1K).
Few days later, at E18.5, numerous Pax 4/h-gal+ cells
coexpressed insulin (Fig. 1M); however, none seemed to
express glucagon (Fig. 1N). The fact that Pax4 activity is
also required for the formation of pancreatic y cells (Sosa-
Pineda et al., 1997) suggests that in E18.5 Pax4+/ pan-
creata, the small population of Pax4/h-gal+ cells devoid of
insulin immunoreactivity could represent y cells.
In summary, these results indicate that in mouse pan-
creata the expression of Pax4 is largely restricted to embry-
onic stages. Colocalization of Pax4/h-gal immunoreactivity
with various endocrine markers and its exclusion from areas
containing exocrine cells indicate that, during pancreas
organogenesis, Pax4 expression is largely confined to the
endocrine cell population. In mouse embryonic pancreata,
the expression of Pax4 peaks during that period when h-cell
precursors normally start to differentiate (E13.5-E15.5);
moreover, in pancreata of Pax4-heterozygous embryos, we
detected coexpression of Pax4/h-gal protein and insulin at
around those stages. These observations, together with our
previous finding indicating that the pancreata of Pax4-
deficient newborns lack mature h cells (Sosa-Pineda et al.,
1997), raise the possibility that Pax4 is an early regulator of
h-cell differentiation. This hypothesis is supported by the
Fig. 1. Pax4 is transiently expressed in endocrine cells during pancreas organogenesis. In mouse developing pancreata, Pax4-expressing cells are numerous at
E11.5 (A) and E15.5 (E), but not at E18.5 (L). At E15.5, Pax4 is expressed in areas where endocrine (F), but not exocrine (G) cells differentiate. At E18.5,
Pax4-expressing cells locate in areas where islets form (L). Pax4-expressing cells coexpress endocrine markers such as: Ngn3 (B and H, arrows), Islet1 (C and
I, arrows) and insulin (J and M, arrows). Coexpression of Pax4 with glucagon was observed in few cells at E11.5 (D, arrow) and E15.5 (K, arrows), but not at
E18.5 (N; arrow indicates a Pax4-expressing cell). (A–N) are cryosections of Pax4+/ pancreata stained with anti-h-gal antibodies. D, H, I, J, K and N are
confocal images (1 Am optical depth). Asterisks in D indicate background staining. Scale bar is 200 Am.
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expression of various gene products that are normally
detected in early differentiating h cells is missing, as
described below.
The lack of functional Pax4 disrupts early b-cell
differentiation
Based in our previous results, we sought to determine
when during h-cell development is the activity of Pax4
required. To this end, the expression of several h-cell-
specific markers was analyzed between E14.5 (early h-cell
differentiation) and P1-P2 (islet formation) in pancreata of
Pax4-nullizygous mice and wild-type littermates.
The h-cell marker Pdx1 is a homeodomain transcription
factor originally identified as an activator of the insulin and
somatostatin genes (Bramblett et al., 2000; Leonard et al.,1993; Miller et al., 1994; Ohlsson et al., 1993; Peshavaria et
al., 1994). Early in development, Pdx1 is widely expressed in
the pancreas and is required for cell proliferation but not for
generation of the earliest insulin-synthesizing or glucagon-
synthesizing cells (Guz et al., 1995; Jonsson et al., 1994;
Offield et al., 1996). At approximately E14.5, high levels of
Pdx1 become restricted to differentiating h cells (Ohlsson et
al., 1993); high Pdx1 expression remains restricted to h cells
in adult pancreata, and its activity is essential for maintaining
the functionality of these cells (Ahlgren et al., 1998; Brissova
et al., 2002; Dutta et al., 1998; Stoffers et al., 1997). We
previously showed that Pdx1 expression was unaltered at
E10.5 in Pax4/ pancreata, but was profoundly affected in
neonates (Sosa-Pineda et al., 1997). We now extended this
study and found that, although numerous cells expressing
high levels of Pdx1 were present in the E14.5 wild-type
pancreatic epithelia (Fig. 2A), very few were detected in the
Fig. 3. Loss of functional Pax4 does not prevent the expression of Ngn3,
Islet1, Nkx2.2 and Pax6 in pancreatic endocrine cells. At E14.5, a similar
population of h-gal+ cells is observed between pancreata of Pax4+/ (A)
and Pax4/ (B) embryos. In pancreatic tissue of E14.5-E15.5 Pax4/
embryos, Pax4-deficient endocrine cells remain expressing Ngn3 (C,
arrows), Islet1 (D, arrows), Nkx2.2 (E, arrows) and Pax6 (F, arrows). (C–F)
are confocal images (1 Am optical depth). Scale bar is 200 Am.
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observed at E15.5 when insulin expression was analyzed:
few, if any, insulin-expressing cells were detected in Pax4-
deficient pancreatic tissues (Figs. 2B and F). Thus, the
expression levels of Pdx1 are severely affected in early
differentiating h cells that are deficient in Pax4 and this
alteration could explain, at least partially, the cells’ inability
to express insulin.
The homeobox gene Hlxb9, which encodes the transcrip-
tion factor HB9, is widely expressed in the pancreatic
epithelium during early development; Hlxb9 function,
which acts upstream of Pdx1, is required for the formation
of the dorsal pancreatic rudiment and cytodifferentiation of
the ventral pancreas. HB9 is a h-cell marker, and its
persistent expression in mature h cells suggests a role for
HB9 in h-cell physiology (Harrison et al., 1999; Li et al.,
1999). In Pax4-deficient pancreata, the early expression of
HB9, like that of Pdx1, was unaffected (data not shown).
However, after E14.5, HB9 expression was severely re-
duced in the Pax4/ pancreatic epithelium (Fig. 2G), and
this defect persisted until birth (Fig. 2H).
The lack of expression of Pdx1, HB9, and insulin did not
appear to result from defective proliferation or absence of h-
cell precursors, as indicated by the numerous h-gal-express-
ing cells detected in Pax4/ pancreata between E13.5 and
E15.5 (Figs. 3A and B). Furthermore, no overt apoptosis
was detected in this tissue (data not shown). We have also
determined that at these stages, Pax4-deficient endocrine
precursors expressed Ngn3 (Fig. 3C) (Apelqvist et al., 1999;
Gradwohl et al., 2000), an indication that these cells are
most likely correctly specified. In addition, the Pax4-defi-
cient pancreatic cells also exhibited apparently normal
expression of the endocrine markers Islet1 (Fig. 3D) (Ahlg-
ren et al., 1997; Dohrmann et al., 2000; Grapin-Botton and
Melton, 2000; Jensen et al., 2000), Nkx2.2 (Fig. 3E) (SusselFig. 2. Lack of functional Pax4 prevents the expression of Pdx1, HB9 and insulin in h-cell precursors. In E14.5 wild-type pancreata, early-differentiating h-
cells show high expression of Pdx1 (A, arrows) and HB9 (C, arrows); shortly thereafter, these cells initiate insulin synthesis (B, arrows). In E14.5 to E15.5
Pax4/ pancreata, only very few cells express high Pdx1 (E, arrow), insulin (F, arrow) or HB9 (G, arrows). The low expression of Pdx1 in non h-cells of these
mutants remains unaffected (arrowheads in A and E). P1 wild-type h-cells express HB9 (D); however, no HB9 expression is detected in pancreata of Pax4/
newborns (H). Scale bar is 100 Am.
Fig. 4. In Pax4/ pancreatic h-cells, the expression of Nkx6.1 decreases after E15.5. Nkx6.1 becomes restricted to differentiating h-cells at around E14.5 to
E15.5, in wild-type (A, arrows) and Pax4/ (D, arrows) pancreata. At E 18.5, the expression of Nkx6.1 is significantly decreased in Pax4/ pancreata (B and
E, arrows), and no Nkx6.1 immunoreactivity is detectable in P1 Pax4/ pancreata (C and F). Scale bar is 200 Am.
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Sander et al., 1997; St-Onge et al., 1997). Thus, in pancre-
atic endocrine cells Pax4 does not seem to have a major role
in regulating Islet1, Pax6 and Nkx2.2 gene expression.Fig. 5. Early h-cells deficient in Nkx2.2 or Pax6 show altered gene expression.
(arrowheads); however, differentiating h-cells express high levels of Nkx6.1 (arro
unchanged. Differentiating h-cells of Sey/Sey embryos have normal HB9 expressio
and G, arrows) and insulin (D and H). h cells lacking Nkx2.2 do not express HBIn mouse embryos, the transcription factor Nkx6.1
is widely expressed throughout the early pancreatic epithe-
lium; however, at approximately E14.5–E15.5, high levels
of Nkx6.1 become restricted to h-cell precursors (Fig.(A) In E14.5 wild-type pancreata, most epithelial cell express low Nkx6.1
ws). In E14.5 Sey/Sey (E) or Nkx2.2/ (I) pancreata, Nkx6.1 expression is
n (B and F); in these embryos, however, fewer h-cells express high Pdx1 (C
9 (J), Pdx1 (K) or insulin (L). Scale bar is 200 Am.
Fig. 6. Pax4 expression is unaltered in E14.5 Nkx2.2/ or Sey/Sey
pancreata; however, Pax6 expression is severely affected in Nkx2.2/
pancreata. At E14.5, normal expression of Pax4 mRNA is observed in
pancreata of Nkx2.2/ (A, arrows) or Sey/Sey (B, arrows) embryos. In
E14.5 Nkx2.2/ pancreata the population of cells expressing Pax6 mRNA
(C and D, arrows) or Pax6 protein (E and F, red and arrows) is reduced. In E
and F, the pancreatic epithelium was stained with anti-Ecadherin antibodies
(green). Scale bar is 100 Am.
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1998; Jensen et al., 1996, 2000; Oster et al., 1998; Sander et
al., 1997, 2000; Wilson et al., 2003). Nkx6.1 activity is
necessary for maintaining and expanding the population of
h cells (Sander et al., 2000). At E15.5, no obvious changes in
the expression of Nkx6.1 were observed in the pancreata of
Pax4/ embryos (Fig. 4D). However, starting at around
E18.5 the expression of Nkx6.1 appeared drastically de-
creased (Fig. 4E) and became nearly undetectable at birth
(Fig. 4F). These findings indicate that Pax4 contributes to the
maintenance of Nkx6.1 expression in differentiating h cells.
Altogether, these results indicate that the activity of Pax4
is essential for initiating the h-cell differentiation program.
Pax4 does not appear to control proliferation or the speci-
fication of endocrine precursors; however, Pax4 activity in
h-cell precursors appears necessary to increase the level of
Pdx1 expression, to induce HB9 and insulin expression and
to maintain Nkx6.1 expression.
E14.5 Pax6-null pancreata show altered expression of Pdx1
and insulin
Within the Pax family of transcription factors, Pax4 and
Pax6, are the closest structural homologues; these proteins
are most similar in their corresponding paired and homeo-
domain DNA-binding domains (Dohrmann et al., 2000;
Mansouri et al., 1996). Pax4 and Pax6 are expressed in
pancreatich cells, and their respective activities are necessary
for h-cell differentiation (Dohrmann et al., 2000; Sander et
al., 1997; Sosa-Pineda et al., 1997; St-Onge et al., 1997).
Furthermore, previous evidence suggested that in pancreatic
h cells Pax6 participates in controlling Pdx1-(Samaras et al.,
2002) and insulin (Dohrmann et al., 2000; Sander et al., 1997)
gene expression. The phenotypic alterations in h cells of
newborn mice deficient in Pax4 or Pax6, however, are not
identical: in the absence of functional Pax4 insulin-producing
cells are nearly absent (Sosa-Pineda et al., 1997), whereas in
absence of Pax6 the insulin-expressing cell population is
reduced only 3- to 4-fold (Sander et al., 1997; St-Onge et al.,
1997). We then decided to determine whether initiation of h-
cell differentiation might require the coordinated activities of
Pax4 and Pax6. To this end, we performed a detailed
expression analysis of E14.5 pancreata from SeyNEU/SeyNEU
(Pax6-deficient) embryos. SeyNEU mice have a mutation in
Pax6 that disrupts the translation of its encoded protein (Hill
et al., 1991); the pancreatic alterations in SeyNEU mice are
comparable to those found in Pax6-nullizygous animals
(Sander et al., 1997; St-Onge et al., 1997). In contrast with
our previous finding showing that in E14.5 Pax4/ pan-
creata the expression of HB9 was severely affected, no
obvious alterations in HB9 expression were observed in
pancreata of SeyNEU/SeyNEU embryos isolated at this stage
(Figs. 5B and F). On the other hand, similar to the loss of
Pax4, in pancreata of E14.5 Pax6-deficient embryos, the
number of cells expressing high levels of Pdx1 was reduced,
but only about 70% to 75% (Figs. 5C and G) and these werethe only cells that synthesized insulin (Fig. 5H). Also, similar
to Pax4/ embryos, the expression of Nkx6.1 was not
significantly altered in E14.5 SeyNEU/SeyNEU pancreata (Figs.
5A and E). Normal expression of Pax4 transcripts was also
observed at this stage in Pax6-deficient pancreata (Fig. 6B).
Our finding showing that in h cell precursors the lack of
either Pax4- or Pax6 activities affected Pdx1 and insulin
expression could suggest that, during h-cell differentiation,
these transcription factors have partially redundant functions.
However, the fact that early in h-cell differentiation the loss
of functional Pax4, but not Pax6, prevented the expression of
HB9 also raises the possibility that in h-cell precursors Pax4
and Pax6 do not regulate the same set of genes.
E14.5 Nkx2.2-deficient b cells exhibit similar alterations
than those of Pax4
Previous studies indicated that Nkx2.2 is a crucial
regulator of h-cell development (Bramblett et al., 2000;
Schwitzgebel, 2001; Sussel et al., 1998). Similar to the loss
of functional Pax4, the lack of Nkx2.2 activity prevents
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Because of the similarities between pancreata of Pax4-
deficient and Nkx2.2-deficient newborns and our results
showing that Pax4 controls early h-cell differentiation, we
sought to analyze whether Nkx2.2 is also required to initiate
this differentiation process. With this analysis, we found that
in Nkx2.2/– pancreata the expression of HB9 protein was
undetectable at E14.5 (Figs. 5B and J). In addition, as
previously reported by Sussel et al. (1998) none of the cells
in Nkx2.2/ pancreata expressed high levels of Pdx1 (Figs.
5C and K) or insulin (Figs. 5D and L) at around this stage.
On the other hand, similar to Pax4-deficient pancreata, the
expression of Nkx6.1 was not significantly altered in E14.5
Nkx2.2/ pancreata (Figs. 5A and I).
From this analysis, we can conclude that the expression
of at least three early markers of h-cell differentiation (HB9,
Pdx1 and insulin) is similarly affected in pancreata of E14.5
Nkx2.2/ and Pax4/ embryos. Interestingly, while we
found that Pax4 expression remained unaffected in E14.5
Nkx2.2/ pancreata (Fig. 6A), that of Pax6 transcriptsFig. 7. Pax4/ Nkx2.2/ h-cells recapitulate the alterations of Nkx2.2/ pancrea
the Pax4-h-gal reporter are observed in pancreata of E14.5 Pax4/Nkx2.2/ emb
show low levels of Pax6 immunoreactivity (E). In pancreata of newborns (P2), mat
arrow). Cells expressing IAPP are present in pancreata of Pax4/ (G), Nkx2.2/
express high Pdx1 (K–M) or insulin (O–Q). (F and J), (G, K and O) (H, L and
indicate Pdx1 expression in ducts and exocrine cells. Scale bar is 100 Am.(Figs. 6C and D) and Pax6 protein was markedly reduced
(Figs. 6E and F). These results indicate that in pancreatic
endocrine cells, the activity of Nkx2.2 is required to
maintain the expression of Pax6 but not that of Pax4, and
suggest that the function of Pax4 is essential but not
sufficient to promote h-cell differentiation. In addition, this
comparison indicates that in the pancreas Pax4 and Nkx2.2
might control similar regulatory pathways.
Pax4/ Nkx2.2/ pancreata have identical alterations to
those observed in Nkx2.2/ pancreata
To determine possible genetic interactions between Pax4
and Nkx2.2 during h-cell differentiation, we generated
Pax4/ Nkx2.2/ double-nullizygous mice. Pax4+/
Nkx2.2+ / – double-heterozygous mice appeared normal at
birth, survived through adulthood, and did not show any
obvious alterations in pancreatic development or glycemia
(data not shown). On the contrary and as expected from the
corresponding single-gene deficiencies, the Pax4/ta more closely than those of Pax4/ pancreata. Numerous cells expressing
ryos (A). These cells do not express Pdx1 (B), HB9 (C), or insulin (D), and
ure h-cells express IAPP (F), high levels of Pdx1 (J, arrows) and insulin (N,
(H), and Pax4/ Nkx2.2/ (I) newborns (P2); however, these cells do not
P) and (I and Q) are adjacent sections, respectively. Arrowheads in (J–M)
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atic alterations observed in double-nullizygous embryos were
identical to those found in Nkx2.2 – / – littermates. In
pancreata of E14.5 Pax4/ Nkx2.2 /– embryos, we
observed numerous cells expressing the Pax4/b-gal reporter
gene (theNkx2.2 knockout allele does not contain b-gal) (Fig.
7A), as well as cells expressing the pan-endocrine marker
Islet-1 (data not shown). These results indicate that, similar to
the phenotype reported for the functional inactivation of each
single gene, the lack of both Nkx2.2 and Pax4 does not
preclude the formation of pancreatic endocrine cells. How-
ever, total lack of cells expressing high levels of Pdx1 (Fig.
7B), HB9 (Fig. 7C), or insulin (Fig. 7D) in pancreata of E14.5
Pax4/ Nkx2.2/ embryos was highly reminiscent of those
alterations observed at this stage in Nkx2.2/ pancreata.
Furthermore, as in Nkx2.2/– littermates, in the E14.5
double-nullizygous pancreata the expression of Pax6 was
also severely reduced (Fig. 7E).
As previously reported by Sussel et al. (1998), in
pancreata of Nkx2.2-deficient newborns (P2), we also ob-
served cells expressing the h-cell marker islet amyloid
polypeptide (IAPP) (Fig. 7H) that were devoid of high
levels of Pdx1 (Fig. 7L) or insulin (Fig. 7P) proteins. Those
observations led Sussel et al. (1998) to conclude that the
lack of functional Nkx2.2 blocks h-cell differentiation.
Similarly, we have now also identified clusters of cells
expressing IAPP (Figs. 7G and I) that did not express
Pdx1 (Figs. 7K and M) or insulin (Figs. 7O and Q) in the
pancreata of Pax4/ and Pax4/ Nkx2.2/ neonates
(P2). Despite those remarkable similarities between pan-
creata deficient in Pax4 and those deficient in Nkx2.2, the
defects were more profound in the Nkx2.2-null background.
In Pax4-deficient pancreata, just a few cells (at most, 10–15
cells in the whole pancreas; data not shown) coexpressed
high levels of Pdx1, HB9, and insulin. Instead, in pancreata
of Nkx2.2/ or Pax4/ Nkx2.2/ neonates the expression
of those h-cell markers was completely absent. One possi-
bility to explain those differences is that in Nkx2.2-deficient
pancreata the lack of Pax6 expression enhances the severity
of the h-cell phenotype.
Overall, our results from this comparative analysis sug-
gest that Pax4 and Nkx2.2 regulate parallel pathways and
that they are both necessary to initiate the h-cell differen-
tiation program; Pax6, on the other hand, appears to be
necessary for the correct execution of this program.Discussion
In this manuscript, we provide evidence to support the
proposal that Pax4 regulates an early step in h-cell differ-
entiation: the expression of Pax4 peaks when h cells
normally start to differentiate (E13.5-E15.5); the lack of
functional Pax4 prevents the expression of three markers of
early h-cell differentiation; and Pax4 is expressed in differ-
entiating h cells. However, it is likely that the earlyexpression of Pax4 is not exclusively restricted to h-cell
precursors, since we previously showed that Pax4 activity is
also required for the formation of somatostatin-producing
(y) cells (Sosa-Pineda et al., 1997). In addition, we now
observed that few a-cells (glucagon-expressing cells) also
coexpressed low levels of Pax4/h-gal protein in pancreata of
E11.5 and E15.5 Pax4+/ embryos.
Loss of functional Pax4 does not affect the expression of
Ngn3, Islet1, Nkx2.2 or Pax6 in pancreatic endocrine
precursors
In mouse embryos, pancreatic endocrine development
commences once Ngn3 is expressed in a population of
epithelial precursors (Apelqvist et al., 1999; Gradwohl et
al., 2000); this results in endocrine-cell specification and in
principle, activates Pax4-expression (Smith et al., 2003;
Wilson et al., 2003). In Pax4-deficient pancreatic cells, we
detected expression of Ngn3; this result supports the hy-
pothesis that during pancreatic endocrine development Pax4
acts downstream of Ngn3.
The observation that the Nkx family members Nkx2.2 and
Nkx6.1 are broadly expressed in the early pancreatic epithe-
lium (where they colocalize with Ngn3) suggested that they
are expressed in early pancreatic endocrine precursors (Jen-
sen et al., 2000; Sander et al., 2000; Sussel et al., 1998;
Wilson et al., 2003). In those pancreatic endocrine precursors,
the expression of the homeobox genes, Islet1 and Pax6, starts
to be detected once endocrine differentiation has begun
(Ahlgren et al., 1997; Bramblett et al., 2000; Dohrmann et
al., 2000; Jensen et al., 2000; Sander et al., 1997; St-Onge et
al., 1997; Wilson et al., 2003). Our detailed analysis of the
expression of Islet1, Nkx2.2 and Pax6 in E13.5-E15.5 Pax4-
deficient pancreatic cells did not reveal any obvious alteration
in their expression. These results suggest that during pancre-
atic endocrine development, Pax4 acts downstream of those
transcription factors or alternatively, that Pax4 activity is not
required to control their expression. In addition, the finding
that Pax4 expression appears normal in pancreatic tissues of
E14.5 Nkx2.2/ or Pax6-deficient (SeyNEU/SeyNEU) mouse
embryos also suggests that Nkx2.2 and Pax6 do not contrib-
ute significantly to activate Pax4 gene expression.
Loss of functional Pax4 affects the expression of early b-cell
markers
In mouse developing pancreata, Nkx6.1 proteins become
restricted to differentiating h cells after E14.5 (Jensen et al.,
2000; Sander et al., 1997, 2000). Until E14.5–E15.5, no
obvious changes in the expression of Nkx6.1 were observed
in Pax4-nullizygous pancreata. However, starting at ap-
proximately E18.5, the level of Nkx6.1 was drastically
reduced and it was undetectable in the mutant pancreas at
birth. This result indicates that in differentiating h cells the
activity of Pax4 contributes to the maintenance of the
expression of Nkx6.1.
Table 1
Summary of changes in gene expression in pancreatic h cells of Nkx2.2/, Pax4/, Sey/Sey and Pax4/ Nkx2.2/ mice
Nkx2.2/ Pax4/ Sey/Sey Pax4/ Nkx2.2/
E14.5 E18.5a-P1b E14.5 P1 E14.5 E18.5c-P1d E14.5 P1
Nkx6.1 +b a,b +b b +b Less cellsc +b b
Nkx2.2   +b N.d. N.d. N.d.  
Pax4 +b N.d.e   +b N.d.e  
Pax6 Lowb Lowb +b N.d.   Lowb Lowb
Pdx1 b a,b b b,f Less cellsb Less cellsc b b
HB9 b b b b +b N.d. b b
insulin b a,b b b,f Less cellsb Less cellsc,d b b
IAPP N.d. +a,b N.d. +b N.d. N.d. N.d. +b
a Sussel et al., 1998.
b This study.
c Sander et al., 1997.
d St.-Onge et al., 1997.
e Expression normally decays at around this stage; N.d., not determined. Yellow boxes indicate gene(s) inactivated in the corresponding mutants.
f Sosa-Pineda et al., 1997.
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to a subpopulation of pancreatic endocrine cells is one of the
earliest indications of h-cell differentiation; this event
occurs at around E14.5 in mouse development and likely
precedes the onset of insulin expression (Gannon et al.,
2001; Guz et al., 1995; Harrison et al., 1999; Li et al., 1999;
Ohlsson et al., 1993). We have now found that starting at
approximately E14.5, the expression of Pdx1, HB9 and
insulin was nearly absent in Pax4/ pancreata, and this
condition persisted until birth. We have previously shown
that insulin+ cells were present at E10.5 in Pax4-deficient
pancreata (Sosa-Pineda et al., 1997). The lack of insulin
expression that we now observed in this mutant tissue from
E14.5 onwards suggests that Pax4 does not have a direct
role in regulating insulin gene expression. Altogether, the
lack of high levels of Pdx1, HB9 and insulin expression
detected after E14.5 in Pax4-deficient pancreata supports
our hypothesis that Pax4 activity is necessary for initiation
of the h-cell differentiation program. Thus, Pax4 seems to
occupy a high place in the molecular hierarchy that governs
the normal development of pancreatic h cells.
It could be argued that the differences we observed in the
expression of some of the analyzed genes in Pax4-nullyzy-
gous pancreata, is due to the loss of certain cell types.
However, the presence of a large h-gal-expressing cell
population in pancreata of E13.5-E15.5 Pax4/ embryosFig.8. Model of h-cell development. In h-cell precursors, Ngn3 induces the exp
thereafter, they express Islet1 and Pax6. The parallel activities of Pax4 and Nkx2
Pdx1 increases; the expression of HB9 is induced; and the synthesis of insulin enprecludes a possible role of Pax4 as a survival factor. Our
finding that numerous cells in Pax4/ newborn pancreata
continue to express the h-cell marker IAPP raises the possi-
bility that these represent poorly differentiated h cells.
Interestingly, Sussel et al. (1998) also reported previously
the presence of IAPP-expressing cells in pancreata of
Nkx2.2/ newborn mice. This observation and the absence
of cells expressing insulin, Pdx1, glucokinase and Glut2 in
Nkx2.2-deficient pancreata at birth led the authors to propose
that the lack of functional Nkx2.2 blocks the maturation of h-
cell precursors.
The activities of Pax4 and Nkx2.2 are necessary to initiate
b-cell differentiation
Our analysis of gene expression at a stage when h-cell
differentiation normally commences showed remarkable
similarities between pancreata deficient in Pax4 and those
deficient in Nkx2.2 (Table 1). These defects, however, were
more profound in the Nkx2.2-null background. Furthermore,
although pancreatic cells deficient in Pax4 remained
expressing Pax6, in Nkx2.2-deficient pancreata, we only
detected a few cells expressing Pax6 transcripts at E14.5.
This result appears to contradict previous data reporting the
expression of Pax6 proteins in E18.5 Nkx2.2-nullizygous
pancreata (Sussel et al., 1998). However, Sussel et al.ression of Pax4; these cells also express Nkx2.2 and Nkx6.1, and shortly
.2 enable the program of h-cell differentiation, and as a result, the level of
sues. In fully mature h cells, the activity of Pax4 is no longer required.
J. Wang et al. / Developmental Biology 266 (2004) 178–189188(unpublished results) recently corroborated that in E12.5,
E15.5, and E18.5 Nkx2.2-deficient pancreata the levels of
Pax6 mRNA were drastically reduced.
Taken together, we would like to propose a model of h-
cell development (Fig. 8) in which Pax4 is expressed in h-
cell precursors after their specification; at around this time,
these cells also express Nkx2.2 and Nkx6.1 and shortly
thereafter, they express Islet1 and Pax6. The parallel activ-
ities of Pax4 and Nkx2.2 enable the program of h-cell
differentiation, and as a result, the level of Pdx1 increases;
the expression of HB9 is induced; and the synthesis of
insulin ensues. In h cells, the expression of Pax4 gradually
disappears upon maturation. Although Pax4 and Nkx2.2
appear to act in parallel to increase Pdx1 expression, it is
still unclear how this role is accomplished. Pax6, on the
other hand, may have a direct effect on Pdx1 expression by
transactivating the Pdx1 gene. In either case, the loss of
Pax6 expression in Nkx2.2/ pancreatic tissues after E14.5
could explain the more severe h-cell phenotype observed in
these embryos.
In conclusion, we identified Pax4, Nkx2.2 and Pax6 as
crucial regulators of early h-cell development. This knowl-
edge should prove valuable for the development of methods
to differentiate pancreatic endocrine precursors into mature
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